Introduction
The gastrointestinal (GI) tract is considered the largest immunological organ in the human body with both circulating and tissue-specific immune cells either organized in several structures of the lamina propria (LP) or resident within the epithelium. The synergic interactions of immune cells with both epithelial cells and microbiota shape innate and adaptive immune responses, set up the threshold between immune tolerance and effector functions, and also balance the efficacy of checkpoint blockade in cancer immunotherapy (1, 2) . γδ T cells account for a large fraction of human intestinal intraepithelial lymphocytes (IELs) endowed with potent antitumor activities. However, little is known about their origin, phenotype, and clinical relevance in colorectal cancer (CRC). To determine γδ IEL gut specificity, homing, and functions, γδ T cells were purified from human healthy blood, lymph nodes, liver, skin, and intestine, either disease-free, affected by CRC, or generated from thymic precursors. The constitutive expression of NKp46 specifically identifies a subset of cytotoxic Vδ1 T cells representing the largest fraction of gut-resident IELs. The ontogeny and gut-tropism of NKp46 + /Vδ1 IELs depends both on distinctive features of Vδ1 thymic precursors and gut-environmental factors. Either the constitutive presence of NKp46 on tissue-resident Vδ1 intestinal IELs or its induced expression on IL-2/IL-15-activated Vδ1 thymocytes are associated with antitumor functions. Higher frequencies of NKp46 + /Vδ1 IELs in tumor-free specimens from CRC patients correlate with a lower risk of developing metastatic III/IV disease stages. Additionally, our in vitro settings reproducing CRC tumor microenvironment inhibited the expansion of NKp46 + /Vδ1 cells from activated thymic precursors. These results parallel the very low frequencies of NKp46 + /Vδ1 IELs able to infiltrate CRC, thus providing insights to either follow-up cancer progression or to develop adoptive cellular therapies.
The human gut epithelium is home to large numbers of T cells expressing γδ T cell receptors (TCR), which account for the main fraction of all intraepithelial lymphocytes (IELs) (3) . While the exact functions of γδ IELs remain elusive, they have been suggested to control antimicrobial defense, organ homeostasis, and tissue damage repair (4, 5) . Indeed, γδ T cell-deficient mice present abnormalities in gut epithelial morphology, reduced MHC-II expression by enterocytes, and impaired mucosal IgA production (6, 7) . Although γδ T cells originate from common thymic precursors alongside αβ T cells, they are considered innate-like lymphocytes for their rapid and non-MHC-restricted effector responses such as cytotoxicity and secretion of type I cytokines (8) . Human γδ T cells are broadly divided into 2 main Vδ1 and Vδ2 subsets based on their TCRδ chain repertoire (9) . Under homeostatic conditions, Vδ2 cells are mainly enriched in peripheral blood, where they represent about 5% of all circulating T cells and recognize specifically microbial or stress-or tumor-induced phosphoantigens (8, (10) (11) (12) . In contrast, Vδ1 cells are preferentially localized in peripheral tissues such as the gut, skin, and liver. However, very little is known about their organ specificity and local antigen/ligand recognition.
Growing evidence confirmed the important role of γδ T lymphocytes in tumor immune surveillance and provided promising perspectives in cancer immunotherapy (13) . Indeed, both Vδ1 and Vδ2 subsets expanded from peripheral blood are endowed with high antitumor activities against hematological malignances and solid tumors in vivo and in vitro (14) . Therefore, much effort has been made to improve blood γδ T cell-mediated tumor recognition and killing (15) . In this context, we previously showed that the TCR stimulation in vitro induces a de novo expression of natural cytotoxic receptors (NCRs) (mainly NKp30) on circulating Vδ1 T cells, thus remarkably increasing their antitumor effector functions (16) . Therefore, NCRs are no longer considered as specific NK cell activating receptors (aNKR) and are currently being implemented for developing adoptive cellular therapies against cancers (17, 18) .
In contrast to the peripheral blood γδ T cells that have received much attention, both phenotype and antitumor potentials, as well as the mechanisms regulating the homeostasis of human tissue-resident γδ T cells, are still largely unknown. Indeed, while mice share some common innate-like functions of human γδ T cells, they differ significantly in terms of TCR specificity and tissue specialization (19) . Nonetheless, several studies reported that, in different types of human cancers, including colorectal cancer (CRC), high frequencies of intratumoral γδ T cells represent one of most favorable prognostic markers in tumor clinical outcomes (20, 21) . Therefore, there is a pressing need to better characterize human tissue-resident γδ T lymphocytes in order to understand their impact in the physiopathology of cancer.
The present study identifies a subset of gut-resident Vδ1 IELs naturally expressing high levels of NKp46. The presence of this NCR characterizes the largest subset of γδ T cells among intestinal IELs, a population that we could not detect in healthy human skin, lymph nodes, or liver; we also could not detect it in the gut of WT mice strains. NKp46 + /Vδ1 IELs share the same phenotypic and antitumor effector functions of NKp46 + /Vδ1 T cells generated from thymic precursors following activation with IL-2 or IL-15, 2 cytokines highly enriched in gut microenvironment that confer to Vδ1 thymocytes a specific gut tropism. Low frequencies of the NKp46 + /Vδ1 IEL subset in healthy gut specimens of patients affected by CRC are associated with a faster tumor progression and development of metastatic diseases, thus suggesting a protective role and a potential prognostic value of these tissue-resident innate-like lymphocytes in CRC.
Results
Identification of a subset of NKp46 + γδ intestinal intraepithelial T lymphocytes. Human healthy colon specimens obtained from patients who underwent surgical resection for CRC were located at the distal part (≥10 cm in length) of the removed tumor core and were considered "tumor-free/healthy" after a conventional macroscopic and microscopic examination by pathologists. Healthy gut specimens were processed to obtain IELs and LP lymphocytes (LPLs) (Supplemental Figure 1 , A-C; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.125884DS1). As expected (22) , the frequency of γδ T cells appeared to be significantly higher among IELs compared with both LPLs and peripheral blood mononuclear cells (PBMCs) ( Figure 1, A and B ). Unlike circulating γδ T cells, both γδ IELs and LPLs presented high levels of the tissue-resident marker CD69 (23) . The different location of intestinal γδ IELs and LPLs was also confirmed by specific high expression on the first subset, and not on the second one, of CD103, the main adhesion molecule involved in the specific retention of IELs in the epithelial layer ( Figure 1C and ref. 24 ). We also observed that γδ IELs are characterized by significantly higher expression of CD56 and CD8 compared with γδ LPLs, while expressing low surface levels of CD4. These phenotypic features of γδ IELs are also associated with low amounts of inhibitory NKRs (iNKRs) (e.g., NKG2A and KIRs) and high expression of aNKRs (e.g., NKG2C and NKG2D), thus suggesting that γδ IELs are endowed with a high cytolytic potential ( Figure 1D ).
Circulating γδ T cells do not physiologically express NCRs (16) . In contrast, we found that γδ IELs constitutively express high levels of NKp46, while their counterparts from LP showed a significantly lower natural expression of this NCR. Although at a minor extent compared with NKp46, γδ IELs are also NKp44 + in contrast to γδ LPLs and PBMCs that have significantly lower surface levels of this NCR. No significant differences were observed for NKp30 surface levels between γδ T intestinal cells (both IELs and LPLs) and PBMCs ( Figure 1E and Supplemental Figure 1D ). The presence of NKp46 + γδ T cells in the intraepithelial (IE) compartment of human intestine was also confirmed by confocal microscopy (Supplemental Figure 1E ). CD8 + γδ IELs had been first characterized as a subset of unconventional T cells expressing, in their TCR complex, the homodimer CD8αα, which induces cell hyporesponsiveness/anergy (25) . Another study later identified a population of high cytotoxic and immune-regulatory intestinal CD8 + γδ T cells carrying the heterodimer CD8αβ. This latter immunoregulatory subset plays a key role in the homeostasis of gut-associated lymphoid tissue and in the pathogenesis of inflammatory bowel disease (IBD) (26) . Our results showed that, while the entire population of CD8 + γδ IELs express significantly higher levels of α rather than β chain, the subset of NKp46 + /CD8 + γδ IELs coexpresses similar levels of α and β chains in their CD8 receptor ( Figure 1F ). CD45 + /CD3 + IELs from healthy gut specimens were also analyzed by a dimensionality reduction method that used the t-distributed stochastic neighbor embedding (t-SNE) algorithm. Two different and separate clusters of NKp46 -(C1) NKp46 + (C2) γδ IELs were identified on the basis of population boundaries distinguishable on the polychromatic flow cytometry density plots ( Figure 1G ). The related heatmap showed that C1 and C2 are characterized by distinctive phenotypes with higher expression of NKp44, NKp30, CD8β, CD56, NKG2C, and NKG2D and lower expression of inhibitory killer immunoglobin receptors (KIRs) in NKp46 + γδ IELs compared with NKp46γδ IELs ( Figure 1H ).
Taken together, this first set of data indicates that the presence of NKp46 identifies a specific cluster of intestinal CD8 γδ IELs carrying the heterodimer CD8αβ and whose phenotype is likely associated with immune effector functions (e.g., cytotoxicity and cytokine production) rather than immune tolerance.
NKp46 + γδ IELs are Vδ1 restricted and preferentially enriched in human intestine. As expected (25) , γδ IELs comprised higher proportions of Vδ1 T cells in contrast to their counterpart in the blood, known to be mainly Vδ2 restricted (8) . A consistent fraction of γδ LPLs neither express Vδ1 nor Vδ2 chain, a phenomenon that we also observed within both IEL and PBMC compartments, although at a lower extent ( Figure  2A ). Therefore, the intestinal LP compartment might be, together with human liver, another preferential tissue where other γδ T cell subsets, such as the Vδ3 + subset, could reside (27) . Interestingly, we found that NKp46 specifically identifies Vδ1 IELs, while Vδ2 IELs express significantly lower amounts of this NCR. NKp44 marks only a small fraction of γδ IELs, with the Vδ1 subset expressing significantly higher levels of this NCR compared with the Vδ2 population. Both Vδ1 and Vδ2 IELs express very low levels of NKp30 ( Figure 2 , B and C). Vδ1 IELs are characterized by a CD4 -/CD8 + phenotype with high surface levels of CD56 and NKG2D, while expressing low amounts of NKG2A and KIRs. In contrast, Vδ2 IELs express significantly lower levels of CD8 and CD56 together with significantly higher amounts of NKG2A when compared with their Vδ1 counterpart ( Figure 2D ). We then purified IELs from matched healthy ileum and colon specimens from patients affected by Crohn's disease and having undergone surgical gut resection. We found similar frequencies of Vδ1 and Vδ2 T IELs both in ileum and colon, with a higher percentage of Vδ1 compared with Vδ2 cells (Supplemental Figure 2A) . Again, the NKp46 expression in the ileum is mainly restricted on Vδ1 IELs in both anatomical sites without any statistically significant differences between ileum and colon (Supplemental Figure 2B ). These results indicate that NKp46 + /Vδ1 lymphocytes represent the largest and most ubiquitous γδ T cell population within the IEL compartment of both small and large intestine.
We then determined the constitutive NCR expression on γδ T cells purified from other human healthy tissues known to be highly enriched of these innate-like T cells: skin, liver, and lymph nodes (5, 28) . Although skin and liver are predominantly enriched with the Vδ1 cell subset over the Vδ2 subset, they do not express NCRs in both tissue sites. Similarly, also Vδ1 and Vδ2 T cells purified from lymph nodes are NKp46and NKp44 -, while a minor fraction of both subsets is NKp30 + (Supplemental Figure 3 ).
Even though murine and human γδ T cells differ in several phenotypic features and tissue distribution, Vδ1 T cells have been shown to be more similar between the 2 species compared with their Vδ2 counterparts (19) . Moreover, NKp46 is the only NCR to be phylogenetically conserved in mice and humans (29) . Therefore, we investigated whether human NKp46 + /Vδ1 IELs have an equivalent in the intestine of BALB/c and C57BL/6 mice strains. Although murine gut contains high frequencies of γδ T IELs, they do not express NKp46. Instead, tissue-resident NK cells from the same murine specimens express, as expected, detectable levels of this NCR and were used as internal positive controls of these experiments in mice (Supplemental Table 1 and Supplemental Figure 4 ). We also found that the degree of frequency of total γδ IELs and NKp46 + /Vδ1 IELs in the intestine is independent of both age and sex (Supplemental Figure 5 ).
Common features but distinct TCR repertoire of NKp46 + and NKp46 -IEL subsets. The repertoire of γδ TCR was analyzed via high-throughput sequencing of V(D)J regions of either the γ chain (TRG) or δ chain (TRD) expressed on FACS-sorted Vδ1 NKp46 + and NKp46 -IELs. The purity of all sorted samples was ≥ 95% (Supplemental Figure 6 ). Our data showed that the TRG repertoires of total NKp46 + and NKp46 -Vδ1 IELs is mainly represented by highly expanded Vγ9γδ T cell clones ( Figure 3A ). We also observed more recurrent usage of Vγ4 + sequences in the NKp46 + IEL subset among different individuals ( Figure 3B ). On the other hand, extended variability of Vγ chains with similar incidence of Vγ9 + and Vγ4 + sequences were presented in NKp46 -IELs. For TRD repertoires, we found a considerable fraction of Vδ2 + sequences within Vδ1 IELs (data not shown), a phenomenon highly similar to what was recently observed in human Vδ1 γδ thymocytes (30) . We then focused our analyses only on Vδ1 + IELs, and the results showed that the sequences of NKp46 + and NKp46γδ subsets were characterized by highly clonal TRD repertoires; the majority of Vδ1 TRD clones used the Jδ1-joining element ( Figure 3C ). Notably, the overall TCR repertoire diversity is largely similar between NKp46 + and NKp46 -IELs ( Figure 3D ). The number of shared TRG and TRD clones, calculated between all samples, shows only a few overlapping clones within the γδ IEL compartment, mainly Vγ4 + or Vγ9 + ( Figure E) . Importantly, the most expanded TRG and TRD clones do not overlap between NKp46 + and NKp46γδ IELs within the same individual ( Figure 3 , A, C, and E). Taken together, the predominant individual clonal TRD and TDG repertoires of NKp46 + and NKp46 -IEL subsets and the lack of overlapping clones between NKp46 + and NKp46γδ IELs suggest that these 2 IEL subsets emerge from distinct Vδ1 T cell progenitors.
NKp46 expression on γδ IELs is associated with high cytolytic potential and production of IFN-γ. Cytokines such as IL-10, IL-17, IL-22, and TGF-β play important roles in regulating intestinal immune system homeostasis and are highly enriched in the gut mucosa microenvironment (31) . In addition, studies have shown that freshly isolated and activated γδ IELs express high levels of lymphotactin/XCL1, a chemokine important for CD8 + T cell activity and chemotaxis (32) . Therefore, we compared the transcription levels of these cytokines between circulating γδ T cells and fresh FACS-sorted NKp46 + and NKp46γδ IELs. Our results showed that both NKp46 + and NKp46γδ IELs express similarly high mRNA amounts of IL-22 and lymphotactin/XCL1 compared with blood γδ T cells, thus highlighting their key roles in IE immune responses and homeostasis. No differences were found for IL-10, IL-17, and TGF-β transcripts between NKp46 + and NKp46γδ IELs and circulating γδ T cells ( Figure 4A ). We then analyzed their IFN-γ production and cytolytic potential after coculture with K562 cells, a tumor target widely employed to test innate cell cytotoxicity (33) . NKp46 + and γδ IELs showed a significantly increased production of IFN-γ in response to the K562 cells compared with their NKp46counterparts ( Figure 4B ). We then observed that the intracellular level of Granzyme B (GZMB) is constitutively higher in freshly purified NKp46 + γδ IELs compared with their NKp46counterparts. The incubation with K562 cells further increased the amount of newly synthesized intracellular GZMB both in NKp46 + and NKp46γδ IELs. However, the amounts of this cytotoxic granule were significantly higher in the first subset compared with the second one ( Figure 4C ). We then measured the degree of CD107a expression as a marker of cytolytic activity. Again, the frequencies of CD107a + /NKp46 + γδ IELs were significantly higher compared with those of CD107a + /NKp46γδ IELs following incubation with K562 ( Figure 4D ). Additional experiments also confirmed the great cytotoxic potential of NKp46 + γδ IELs in killing human colon adenocarcinoma cell targets (e.g., SKCO1 and Caco2) ( Figure 4E ).
To assess the functional relevance of NKp46 in the highly cytotoxic potentials of NKp46 + γδ IELs, we tested the ability of these cells to degranulate either in the presence or in the absence of the specific anti-NKp46 mAb. The results showed that the masking of NKp46 significantly decreases the ability of NKp46 + γδ IELs to kill K562 ( Figure 4F ), thus demonstrating a direct involvement of this aNKR in tuning the cytotoxicity of this specific epithelial γδ T cell subset.
Human γδ thymocytes resemble the phenotype and functions of NKp46 + Vδ1 IELs following activation. Maturation of γδ T cells occurs during thymus development that commits γδ T precursors to properly differentiate and migrate to peripheral tissues (34) . Recently, it has been also reported that the acquisition of both cytotoxicity and ability to produce IFN-γ by γδ thymic precursors is not associated with the engagement of TCR, but rather requires activation with either IL-2 or IL-15 (35) . In order to understand whether these 2 cytokines could induce phenotype and functions similar to those of NKp46 + Vδ1 IELs at the level of γδ thymic precursors, we stimulated, with both these cytokines, γδ thymocytes purified from healthy thymus collected from pediatric patients undergoing cardiac surgical procedures. The activation with either IL-2 or IL-15 induced a statistically significant increase of NKp46, while this was not the case for γδ thymocytes incubated with IL-7 ( Figure 5A ). Interestingly, the activation with IL-2 induced a preferential expansion of the NKp46 + /Vδ1 T cell subset, as we did not detect any significant proliferation within the Vδ2 cell compartment ( Figure 5, B and C) . The expansion of Vδ1 thymocytes was mainly associated with an increased de novo expression of NKp46, as we observed very few NKp46 + /Vδ1 cells in freshly isolated thymocytes (data not shown). We also found that IL-2 activation induces a de novo expression of NKp46 on FACS-sorted Vδ1 thymocytes and not on their Vδ2 FACS-sorted counterparts, thus indicating the intrinsic ability of this cytokine to generate NKp46 + /Vδ1 T cells from their thymic Vδ1 precursors without the need of additional cellular interactions (data not shown).
Activation with IL-2 induces, on γδ thymocytes, a significant de novo expression of NKp44 and NKp30 receptors, although to a lesser extent compared with that of NKp46. In contrast, we did not detect any induced expression of NCRs on αβ thymocytes or peripheral γδ T cells following incubation with IL-2 ( Figure 5D ). Similar results were observed with IL-15 (data not shown).
Interestingly, the phenotype of Vδ1 cells expanded from IL-2-activated γδ thymic precursors resembled the phenotype of NKp46 + /Vδ1 IELs freshly purified from human intestine. Indeed, the incubation with IL-2 (and with IL-15, as well; data not shown) increased on proliferating Vδ1 thymocytes the expression of CD8, CD56, and NKG2D ,while decreasing the surface levels of CD4. Only NKG2A was differently expressed on Vδ1 + cells generated from IL-2 activated thymic precursors compared with freshly purified intestinal NKp46 + /Vδ1 IELs. Indeed, while this latter subset naturally expresses very low levels of this iNKR, the stimulation of thymic precursors with IL-2 induced a remarkably high de novo expression of NKG2A on Vδ1 + thymocytes. The IL-2 stimulation also triggered a de novo expression on Vδ1 + cells of CCR9, a chemokine receptor involved in the homing of γδ T lymphocytes to the gut mucosa ( Figure 6A and ref. 36 ). This phenomenon is also functionally relevant, as demonstrated by the chemotactic activity of CCR9 on IL-2-activated NKp46 + /Vδ1 thymocytes in response to its CCL25 ligand in a dose-dependent manner ( Figure 6B ). The acquisition of the NKp46 phenotype on γδ thymocytes following incubation with IL-2 is coupled with significantly higher transcription levels of GZMB, as well as with an increased degranulation against K562 and human tumor epithelial colorectal Caco2 cell lines ( Figure 6 , C and D).
Taken together, these data indicate that IL-2/IL-15-mediated differentiation of human Vδ1 thymic precursors results in the acquisition of the gut-like phenotype and potent antitumor activity by these cells, which might be committed to specifically migrate to the gut.
Impact of intestinal microenvironment in the maturation of IL-2-activated γδ thymocytes. The preferential enrichment of NKp46 + /Vδ1 T cells in the intestinal epithelium implicates a tight interaction with intestinal epithelial cells (IECs). Indeed, the survival and the retention of IELs depends on the ligand-activated transcription factor aryl hydrocarbon receptor (AHR) and IL-15 production by neighboring IECs (37) . Therefore, we incubated γδ thymocytes with IL-2 in the presence or absence of either primary human colonic epithelial cells (HCoEpic) or IL-15. Both these factors had a significant synergistic effect in further increasing the expression of NKp46 on IL-2-activated Vδ1 proliferating thymocytes ( Figure 6E) . In contrast, we did not observe any change in NKp46 expression on IL-2-activated thymocytes cocultured with IL-10, IL-12, IL-22, or thymic stromal lymphopoietin (TSLP), the soluble factor produced by IECs to induce T cell maturation at this tissue site (38) (data not shown). We also analyzed the contribution of TGF-β that is overexpressed in CRC with poor prognosis, where this protein plays a key role in the organization of tumor microenvironment (39) . The incubation with TGF-β significantly suppressed the IL-2-induced expression of NKp46 on proliferating γδ thymocytes. Similar inhibitory results were obtained when IL-2-stimulated γδ thymocytes were cocultured with Caco2 cells ( Figure 6E ), thus confirming that the intestinal tumor microenvironment is endowed with escape mechanisms impairing the cytolytic potential of Vδ1 T cells.
Impact of NKp46 + /Vδ1 IELs on the prognosis and progression of CRC. We then assessed if the frequency of γδ IELs in the "disease-free/healthy" tissue specimens of patients affected by CRC correlated with tumor progression. To this end, patients included in the analysis were divided into 2 subcohorts either in early (I/II) or late (III/IV) tumor-nodes metastasis (TNM) stages of CRC on the basis of the widely used TNM staging system. Patients who required chemotherapy treatment before surgical resection of CRC were excluded from the analyses to avoid any bias on T lymphocytes recurrence. We first observed that the frequencies of total γδ IELs, as well as of their Vδ1 and Vδ2 subsets, did not change in the portions of healthy colon from CRC patients at different TNM disease stages (Figure 7, A and B) . Interestingly, we found that tumor-free gut specimens of CRC patients that progressed toward stages III/IV had a significantly lower frequency of NKp46 + /Vδ1 IELs compared with those at earlier I/II stages. This phenomenon appeared to be specific for NKp46 + /Vδ1 IELs, since no changes in the frequencies of NKp46 + /Vδ2 IELs were found between I/II and III/IV CRC stages (Figure 7, C and D) .
We then evaluated the ability of the NKp46 + /Vδ1 subset to infiltrate CRC tumor mass. Since this adenocarcinoma originates directly from tumor-transformed IECs and typically disrupts the anatomical organization of gut mucosa in epithelial and LP compartments (Supplemental Figure 1B and ref. 21) , we measured the frequency of tumor infiltrating lymphocytes (TILs) on the entire pathologic specimens without distinguishing between IELs and LPLs. We found that the percentages of both total Vδ1 and the NKp46 + / Vδ1 TIL subsets within CRC tumor mass were significantly lower compared with the frequencies of IELs in disease-free/healthy gut tissue specimens (Figure 7 , E and F). Since patients affected by IBD are at higher risk of developing CRC (40), we also evaluated the frequency of both Vδ1 cells and the NKp46 + /Vδ1 cell subset in patients with ulcerative colitis (UC). Again, the percentages of both of these intestinal lymphocyte populations in the UC gut specimens were significantly lower compared with the frequencies of their IEL counterparts in disease-free/healthy gut tissue specimens (Supplemental Figure 7) . Taken together, these data suggest that both inflammatory and tumor microenvironments are associated with escape mechanisms inhibiting either the migration or the in situ expansion of antitumor NKp46 + /Vδ1 IELs.
Discussion
NKp46 is one of the 3 NCRs originally identified as germline-encoded proteins specifically expressed on circulating NK cells and playing key roles in cancer immune surveillance (41) (42) (43) (44) . Although NCRs are naturally absent on circulating T cells (17), both NKp46 and NKp44 were previously found to be expressed on human intestinal αβ T IELs of patients affected by celiac disease (45) . In this context, a T cells generated from thymocyte precursors cultured with IL-2 for 6 days (n = 8). (C) Summary statistical graphs showing the transcripts levels of GZMB and NKp46 transcripts on freshly FACS-sorted thymocytes (Ctrl) and on NKp46 + and NKp46 -Vδ1 T cells generated from thymocyte precursors cultured with IL-2 for 6 days (n = 6). Results are represented as the fold change (2 -ΔΔCT ) of target gene relative to a Ctrl samples and normalized to housekeeping genes GAPDH and S18. (D) Summary statistical graphs showing the expression of CD107a on NKp46 + and NKp46 -Vδ1 T cells generated from thymocyte precursors cultured with IL-2 for 6 days either in the absence (Ctrl) or in the presence of K562 or Caco2 human tumor target cells (n ≥ 9). (E) Summary statistical graphs showing the NKp46 expression on freshly purified thymocytes (day 0) and on γδ thymocytes cultured with IL-2 for 6 days either in the absence (Ctrl) or in the presence of primary human colonic epithelial cells (HCoEpic) or IL-15, TGF-β, or Caco2 cell lines (n ≥ 8). *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001. major role was played by IL-15, a proinflammatory cytokine overexpressed in celiac patients and inducing the expansion of activated NCR + αβ IELs endowed with potent NK-like and TCR-independent antitumor effector functions (46) . However, these cytotoxic NCR + αβ IELs were highly restricted in their TCR repertoire, likely indicating a previous TCR engagement (47) . The present study identifies a subset of Vδ1 cells constitutively expressing high levels of NKp46 and representing the largest γδ IEL subset in healthy human intestine. NKp46 + /Vδ1 IELs are not phylogenetically conserved across species (e.g., mice and humans) and are not present in blood and other human tissue compartments highly enriched in γδ T cells. Therefore, they represent a unique population of gut-resident innate-like lymphocytes and a first line of immune-defense against infections and tumors at mucosal interface. This is, to our knowledge, the biggest natural (contrasting to induced) (16) NCR + T cell subset yet identified.
In this study, we also established a methodology able to induce an NCR + phenotype on pediatric γδ thymocytes in vitro upon stimulation with IL-15 or IL-2, which are the 2 cytokines playing key roles in boosting the γδ T cell cytotoxicity program (35) . This is consistent with a previous report showing that both IL-15 and IL-2 (but not IL-7) induces NCR expression and cytotoxicity on T cells (both αβ and γδ) purified from cord blood (48) . Further investigation is needed to understand the kinetics and the mechanisms required in vivo, at the thymus site, to induce the expression of NKp46 on Vδ1 thymocytes, as well as their ability to migrate to gut epithelium.
We previosly reported an inducible expression of NCRs (with NKp30 being the dominant family member) also on circulating γδ T cells from adult donors, a phenomenon occurring selectively on the Vδ1 T cell subset and requiring both IL-15/IL-2 cell activation and TCR engagement (16) . NCR + /Vδ1 T cells generated from peripheral blood hold great potential for adoptive cell therapy, as they displayed both in vitro and in vivo (xenograft models) enhanced cytotoxicity against hematological tumors and potent antiviral activities (49, 50) . We show here that the constitutive expression of NKp46 on freshly purified Vδ1 IELs, as well as its induced expression on IL-2/IL-15-stimulated Vδ1 thymocyte precursors, remarkably increase the cytolytic potential of these innate-like lymphocytes against solid (epithelial-derived) tumors, as well.
Taken together, these data demonstrate that the presence of NCRs identifies a subset of highly cytotoxic γδ T cells either normally resident in the human gut epithelium or expanded in vitro from different sources.
The origin and development of IELs is still the subject of debate. A murine model showed that γδ thymocytes follow maturation waves that sequentially populate different tissues, starting with skin at an early embryonic age and followed by tongue, reproductive tract, and intestine at peri-and postnatal days (51) . In the gut, there are multiple cellular sources of IL-15, including IECs (37) . On the other hand, IL-2 secreted by the neighboring αβ IELs supports the growth of γδ IELs (52) . This explains, at least in part, the fact that the intestinal epithelium rather than LP is the preferential natural anatomical location for the newly disclosed NKp46 + /γδ IELs. We show here that IL-2 or IL-15 stimulation induces in thymocyte precursors the phenotype and functions of NKp46 + /Vδ1 IELs, as well as the expression of CCR9, thus promoting a specific homing of these cells to the IEL compartment (36) . In this regard, although IL-2/IL-15-activated γδ thymocyte precursors share several similarities both in phenotype and functions with freshly purified and gut-resident NKp46 + /Vδ1 IELs, this latter population lacks the expression of NKG2A in contrast to what we observed in IL-2/IL-15-stimulated thymocytes. The different surface distribution of this iNKR is likely associated with the fact that NKp46 + /Vδ1 T cells generated in vitro from thymic precursors do not directly interact with IECs naturally expressing high levels of the nonclassical MHC, Class I, E (HLA-E). This nonclassical MHC-I complex represents the NKG2A natural ligand, whose constitutive high surface level on IECs is a consequence of their chronic stress and antigen challenges occurring at the mucosal interface (53) . Therefore, the binding of HLA-E with NKG2A on NKp46 + /Vδ1 intestinal IELs might explain its low detectable expression as a mechanism of induced peripheral tolerance under homeostatic conditions and in the presence of alloantigen stimulation. Indeed, NKp46 is involved in the killing of various cancer cells following binding with its natural ligands expressed on cancer cells, a phenomenon also associated with cytoskeletal rearrangement and higher lytic granule polarization to the immune synapse (41, 43, 44, 54, 55) . We demonstrate here that the expression of this NCR significantly contributes to the high cytolytic potential of NKp46 + /Vδ1 IELs freshly purified from the gut, since its blocking remarkably reduces this effector function. Therefore, while NKp46 expression marks an enhanced cytotoxicity among γδ IELs, other receptors such as NKG2A might represent an immune checkpoint controlling the effector functions of NKp46 + /Vδ1 intestinal IELs. Additional studies are required to disclose the mechanisms modulating the immune surveillance thresholds of these newly disclosed subsets of gut-resident innate-like lymphocytes. Taken together, these data indicate that the ontogeny and homeostasis of the NKp46 + /Vδ1 IELs depends both on distinctive features of human Vδ1 thymocytes and gut microenvironmental factors.
The clinical relevance of our NKp46 + /Vδ1 IELs subset is highlighted by their possible impact in the natural history of CRC. Indeed, our results showed that lower frequencies of NKp46 + /Vδ1 IELs in healthy intestinal tissues surrounding the tumor mass correlate with a higher tumor progression toward metastatic diseases. Interestingly, a recent report showed that the NKp46-mediated production of IFN-γ by NK cells is able to control tumor progression and decreases metastasis in vivo via the induced secretion of fibronectin by malignant cells (56) . Furthermore, T cells expressing Vδ1 represent the dominant subset among all γδ T cells in CRC patients with an impaired IFN-γ production (21) . Our data showed significantly lower frequencies of both CRC intratumoral Vδ1 and NKp46 + /Vδ1 T cells compared with those of their counterparts naturally resident in the healthy IE gut compartment. Incubations of IL-2/IL-15-activated thymocyte precursors with Caco2 cells or TGFβ (overexpressed in CRC) (39) greatly inhibited the expansion of NKp46 + /Vδ1 Τ cells. Both these ex vivo and in vitro data suggest that the local tumor microenvironment might facilitate tumor progression by escaping NKp46 + /Vδ1 IEL cytotoxicity. A recent study reported that the loss of butyrophilin-like (BTLN) molecule BTLN8 coincides with permanent loss of the specific gut-resident BTLN3/8 reactive Vγ4 + /Vδ1 IEL subset upon inflammatory conditions in celiac disease (57) . Additional investigations are required to assess if a similar mechanism also contributes to the reduce NKp46 + /Vδ1 T cells in human model of cancer like CRC.
In summary, our identification of a gut-resident subset of NKp46 + /Vδ1 IELs endowed with enhanced antitumor potential paves the ground for developing novel approaches in the field of immune therapy. Indeed, both the possibility of generating, from thymic precursors in vitro, NKp46 + /Vδ1 T cells with high tropism for the gut and the Delta One T cell protocol (45) -which upregulates NCRs expression on Vδ1 T cells while expanding them to large numbers for adoptive transfer -represent promising and alternative ad hoc strategies for CRC treatment.
Methods
Human specimen processing and cell culture. Healthy intestine tissues were collected from the distal area of the pathological tissue (≥10 cm) and macroscopically free from any disease. In order to obtain intestinal IELs from healthy intestine tissues, gut mucosa was first dissected from the whole tissue and cut in small pieces, washed in wash buffer (WB) prepared with HBSS buffer without Ca 2 and Mg 2 (HBSS -/-; Lonza) supplemented with 1% penicillin/streptomycin/amphotericin (P/S/A; Invitrogen), treated with 2 mM of DL-Dithiothreitol (DL-DTT) (Sigma Aldrich) for 15 minutes at room temperature (RT), washed again, and subsequently treated with 2 mM of EDTA (Sigma Aldrich) for 30 minutes at 37°C/5% CO 2 . Both cell suspensions were filtered through a 100-μm cell strainer (Thermo Fisher Scientific), and cells were collected by centrifugation (400 g, 10 minutes). The remaining tissue was used to isolate LPLs by enzymatic digestion with 0.75 mg/mL of collagenase II (Sigma-Aldrich) for 1 hour at 37°C/5% CO 2 . Obtained cells were filtered through a 100-μm cell strainer and collected by centrifugation (400 g, 10 minutes). Finally, both IELs and LPLs were isolated using 30/70% Percoll gradient (Sigma-Aldrich) by centrifugation (900 g for 20 minutes). Pathological intestine specimens were mechanically minced in small pieces and washed with WB, followed by enzymatic digestion with 1.5 μg/mL of collagenase IV (Invitrogen), 20 μg/mL of hyaluronidase, and 50 μg/mL of DNAase (both from Sigma Aldrich) for 2 hours at 37°C/5% CO 2 . Obtained cells were isolated by centrifugation (400 g, 10 minutes) and stained for flow cytometry analysis (Supplemental Figure 1 , A-C).
Human healthy thymus samples were obtained from children undergoing heart surgery for congenital heart diseases according to current clinical practice. Thymic tissue was cleaned from blood vessels and fat tissue and cut in small pieces. Thymocytes were recovered through mechanical smashing and kept in PBS (Corning) with 1% of P/S, to preserve their viability or were frozen in FBS (Lonza) with 10% of DMSO (Lonza) and stored at -80°C. Thawed thymocytes were cultured in 96-well round-bottom plates at a concentration of 1 × 10 6 cells/mL in X-VIVO 15 serum-free hematopoietic cell medium supplemented with 5% human AB serum, 1% P/S/A, 1% ultraglutamine, 1% Na pyruvate, and 1% of nonessential amino acid solution (NEAA), all purchased from Lonza. Thymocytes cultured in vitro were stimulated with human recombinant IL-2 (200 U/mL, Miltenyi Biotec) or with IL-15, IL-7, IL-10, IL-12, IL-22, TGF-β, or TSLP, all used at concentration 10 ng/mL and purchased from Peprotech.
Human healthy liver tissues were obtained from patients who underwent hepatectomy for hepatic metastatic disease from CRC. Tissue specimens were collected from the distal area of the pathological tissue (≥4 cm) and macroscopically free from any disease. Liver tissue dissociation was obtained by enzymatic digestion in gentleMACS Dissociator (Miltenyi Biotec) with 2 mg/mL of collagenase D (Roche Diagnostics) for 45 minutes at 37°C/5% CO 2 . Cells then were filtered through 100-μm cell strainers and washed in HBSS -/-, and lymphocytes were separated using 30/70% Percoll gradient.
Human healthy skin was obtained from patients undergoing abdominoplasty or mastoplasty surgical procedures. Skin specimens were cut in small pieces, and lymphocytes were recuperated by enzymatic digestion with 1.25 U/mL of Dispase II (Roche Diagnostics) initially for 16 hours at 4°C, followed by 30 minutes at 37°C. Solution containing epidermal lymphocytes was filtered through 100-μm cell strainers, and cells were washed in HBSS -/-with5 mM EDTA. Remaining tissue was further digested with 1 mg/mL collagenase D and 1.25 U/mL of Dispase II for 30 minutes at 37°C in order to recover dermis lymphocytes. Cells then were filtered through 100-μm cell strainers and washed in HBSS -/with 5 mM EDTA, and lymphocytes were separated using 30/70% Percoll gradient.
Human healthy/nonreactive lymph nodes were obtained from patients with Whartin's tumor or hyperplasia of salivary glands. Lymph nodes were mechanically smashed in HBSS -/through 100-μm cell strainers, and cells were collected by centrifugation (400 g, 30 minutes).
Human PBMC were isolated from buffy coats of healthy volunteers (HRH) using Lympholyte Cell Separation density gradient solution (Cederlane Laboratories) according to the manufacturer's instruction.
Primary HCoEpic (catalog 2950; ScienCell Research Laboratories) were cultured on poly-L-lysine (Sigma-Aldrich) following manufacturer's instructions in the specific colonic epithelial cell medium (CoEpiCM, catalog 2951) supplemented with colonic epithelial cell growth supplement (CoEpiCGS, catalog 2952) and 1% P/S/A.
